Literature DB >> 31650

Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.

S A Persson.   

Abstract

In the rat, lysergic acid diethylamide (LSD) 0.5 mg/kg and 2-bromo lysergic acid diethylamide (BOL) 0.5 mg/kg increased the rate of the striatal in vivo tyrosine hydroxylation as measured by the DOPA accumulation after decarboxylase inhibition. Neither LSD nor BOL significantly changed the DOPA accumulation in the olfactory tubercle, a dopamine-rich part of the limbic system. LSD but not BOL increased the DOPA accumulation in the cerebral cortex and in the brain stem. LSD and BOL appeared not to alter the rate of alpha-MT-induced disappearance of DA or of NA in the whole brain, nor did they change the rate of the alpha-MT-induced disappearance of DA in the striatum. It is suggested that in the striatum LSD and BOL block autoreceptorss (presynaptic receptors) regulating the tyrosine hydroxylation. These receptors may be DA receptor, but may also be 5-HT- or LSD-sensitive receptors. The regional differences observed between LSD and BOL suggest that LSD in the cerebral cortex and in the brain stem increases the DOPA accumulation by mechanism other than that functioning in the striatum. One possible explanation is that LSD and BOL may differ in their effects on 5-hydroxytryptaminergic systems in the cerebral cortex and in the brain stem.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31650     DOI: 10.1007/bf00427743

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.

Authors:  R A Lovell; D X Freedman
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

2.  LSD and 2-bromo-LSD: comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala.

Authors:  G K Aghajanian
Journal:  Neuropharmacology       Date:  1976-09       Impact factor: 5.250

3.  The effect of LSD and 2-bromo LSD on the DOPA accumulation after central and peripheral decarboxylase inhibition.

Authors:  G Hollunger; S A Persson
Journal:  Eur J Pharmacol       Date:  1975-03       Impact factor: 4.432

4.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.

Authors:  N E Andén; H Corrodi; K Fuxe
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

6.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

7.  Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.

Authors:  M K Menon; W G Clark; D T Masuoka
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

8.  The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.

Authors:  S A Persson
Journal:  Eur J Pharmacol       Date:  1977-05-01       Impact factor: 4.432

9.  Distribution of dopamine in the rat cerebral cortex.

Authors:  W Kehr; M Lindqvist; A Carlsson
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

10.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

View more
  1 in total

1.  LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Authors:  V J Watts; C P Lawler; D R Fox; K A Neve; D E Nichols; R B Mailman
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.